Flexicam

RSS

meloxicam

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Flexicam has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 20/05/2014

Authorisation details

Product details
Name
Flexicam
Agency product number
EMEA/V/C/000102
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Dechra Veterinary Products A/S
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
10/04/2006
Contact address
Mekuvej 9
7171 Uldum
Denmark

Product information

06/05/2014 Flexicam - EMEA/V/C/000102 - IB/0012

This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Antiinflammatory and antirheumatic products

Therapeutic indication

Oral suspension:

Dogs:
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.

Solution for injection:

Dogs:
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.

Cats:
Reduction of postoperative pain after ovariohysterectomy and minor soft tissue surgery

Assessment history

How useful was this page?

Add your rating
Average
1 rating
1 rating